An ongoing clinical trial of four experimental Ebola treatments will start to enroll participants at two outbreak hot spots in the Democratic Republic of Congo, Doctors Without Borders announced Feb. 12.
Three things to know:
1. The clinical trial, launched in November, seeks to identify the most effective Ebola treatment of four experimental therapies: Remdesivir, mAb114, REGN-EB3 and ZMapp.
2. The trial will now involve Ebola patients in treatment centers in Katwa and Butembo — current hot spots of Congo's Ebola outbreak.
3. As of Feb. 11, the World Health Organization reported 819 confirmed and probable infections linked to the outbreak, which started in August.